Name: Hauke Baumann

Date of Birth: January 19th, 1991

Place of Birth: Celle, Germany

Position/Title: PhD student at the Institute of Neurogenetics in the research section “Genetics of Rare Diseases”

Address: Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany

Phone: +49-451-31018209

Email: hauke.baumann@neuro.uni-luebeck.de

Identification and characterization of novel genetic causes of movement disorders.

10/2010 – 09/2013: Studies of Biology at the University of Würzburg

04/2013 – 07/2013: Bachelor thesis, University of Würzburg, Institute of Physiological Chemistry (Director: Prof. M. Schartl), supervised by PD S. Meierjohann
Bachelor of Science

10/2013 – 04/2016: Studies of Biology at the University of Kiel
04/2015 – 10/2015: Master thesis, Leibniz-Center for Medicine and Biosciences, Borstel (Director: Prof. S. Ehlers), supvervised by PD N. Reiling
Master of Science

05/2016 – present: PhD thesis, University of Lübeck, Institute of Neurogenetics (Director: Prof. C. Klein), supervised by Prof. K. Lohmann

Other Advanced Training

10/2018: – Whole Transcriptome Data Analysis, EMBL Course, Heidelberg, Germany

Movement Disorder Society (MDS)

European Society of Human Genetics (ESHG)

  1. Dulovic-Mahlow M, Trinh J, Kandaswamy KK, Braathen GJ, Di Donato N, Rahikkala E, Beblo S, Werber M, Krajka V, Busk ØL, Baumann H, Al-Sannaa NA, Hinrichs F, Affan R, Navot N, Al Balwi MA, Oprea G, Holla ØL, Weiss MER, Jamra RA, Kahlert AK, Kishore S, Tveten K, Vos M, Rolfs A, Lohmann K. De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders. Am J Hum Genet 2019;1:213-220.
  2. Dulovic-Mahlow M, Gajos A, Baumann H, Pozojevic J, Kaiser FJ, Bogucki A, Lohmann K. Highly reduced penetrance in a family with a THAP1 nonsense mutation: Role of THAP1 expression? Parkinsonism & Related Disorders 2019:274-276.
  3. Tunc S, Dulovic-Mahlow M, Baumann H, Baaske MK, Jahn M, Junker J, Münchau A, Brüggemann N, Lohmann K. Spinocerebellar Ataxia Type 28-Phenotypic and Molecular Characterization of a Family with Heterozygous and Compound-Heterozygous Mutations in AFG3L2. Cerebellum 2019;4:817-822.
  4. Klein C, Baumann H, Olschewski L, Hanssen H, Münchau A, Ferbert A, Brüggemann N, Lohmann K. De-novo KMT2B mutation in a consanguineous family: 15-Year follow-up of an Afghan dystonia patient. Parkinsonism Relat Disord 2019:337-339.
  5. Trinh J, Lohmann K, Baumann H, Balck A, Borsche M, Brüggemann N, Dure L, Dean M, Volkmann J, Tunc S, Prasuhn J, Pawlack H, Imhoff S, Lill CM, Kasten M, Bauer P, Rolfs A, International Parkinson’s Disease Genomics Consortium (IPDGC)., Klein C. Utility and implications of exome sequencing in early-onset Parkinson’s disease. Movement Disorders : official Journal of The Movement Disorder Society 2018;1:133-137.
  6. Baumann H, Jahn M, Muenchau A, Trilck-Winkler M, Lohmann K, Seibler P. Generation and characterization of eight human-derived iPSC lines from affected and unaffected THAP1 mutation carriers. Stem Cell Research 2018:60-64.
  7. Lohmann K, Masuho I, Patil DN, Baumann H, Hebert E, Steinrücke S, Trujillano D, Skamangas NK, Dobricic V, Hüning I, Gillessen-Kaesbach G, Westenberger A, Savic-Pavicevic D, Münchau A, Oprea G, Klein C, Rolfs A, Martemyanov KA. Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans. Human Molecular Genetics 2017;6:1078-1086.
  8. Baumann H, Wolff S, Münchau A, Hagenah JM, Lohmann K, Klein C. Evaluating the role of TMEM230 variants in Parkinson’s disease. Parkinsonism & Related Disorders 2016:100-101.